4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-007766
Chief Commercial Officer acquired 45,533 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yarema Kristin Chief Commercial Officer | 2022-03-01 | Grant or award | +45,533 | 171,415 | D | ||
| Derivatives | |||||||
| Yarema Kristin Chief Commercial Officer | 2022-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +85,592 | 85,592 | D | ||
Loading xslF345X03/form4.xml…